Generated Narrative: CodeSystem mn-cvx Properties This code system defines the following properties for its concepts Name Code URI Type status status http://hl7.org/fhir/concept-properties#status code Concepts This case-sensitive code system http://hl7.org/fhir/sid/cvx defines the following codes: Code Display Definition status 54 adenovirus, type 4 adenovirus vaccine, type 4, live, oral retired 55 adenovirus, type 7 adenovirus vaccine, type 7, live, oral retired 82 adenovirus, unspecified formulation adenovirus vaccine, unspecified formulation retired 24 Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis Anthrax vaccine, adsorbed, pre-exposure and post-exposure prophylaxis 19 BCG Bacillus Calmette-Guerin vaccine 27 botulinum antitoxin 26 cholera, unspecified formulation cholera vaccine, unspecified formulation retired 29 CMVIG cytomegalovirus immune globulin, intravenous 56 dengue fever tetravalent dengue fever vaccine, tetravalent 12 diphtheria antitoxin 28 DT (pediatric) diphtheria and tetanus toxoids, adsorbed for pediatric use retired 20 DTaP diphtheria, tetanus toxoids and acellular pertussis vaccine 106 DTaP, 5 pertussis antigens diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens 107 DTaP, unspecified formulation diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation retired 110 DTaP-Hep B-IPV DTaP-hepatitis B and poliovirus vaccine 50 DTaP-Hib DTaP-Haemophilus influenzae type b conjugate vaccine retired 120 DTaP-Hib-IPV diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) 130 DTaP-IPV Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated 01 DTP diphtheria, tetanus toxoids and pertussis vaccine retired 22 DTP-Hib DTP-Haemophilus influenzae type b conjugate vaccine retired 102 DTP-Hib-Hep B DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine 57 hantavirus hantavirus vaccine retired 52 Hep A, adult hepatitis A vaccine, adult dosage 83 Hep A, ped/adol, 2 dose hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule 84 Hep A, ped/adol, 3 dose hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule retired 31 Hep A, pediatric, unspecified formulation hepatitis A vaccine, pediatric dosage, unspecified formulation retired 85 Hep A, unspecified formulation hepatitis A vaccine, unspecified formulation retired 104 Hep A-Hep B hepatitis A and hepatitis B vaccine 30 HBIG hepatitis B immune globulin 08 Hep B, adolescent or pediatric hepatitis B vaccine, pediatric or pediatric/adolescent dosage 42 Hep B, adolescent/high risk infant hepatitis B vaccine, adolescent/high risk infant dosage retired 43 Hep B, adult hepatitis B vaccine, adult dosage 44 Hep B, high-dosage, dialysis or IC Hepatitis B vaccine (Hep B), high-dosage, dialysis or immunocompromised patient 45 Hep B, unspecified formulation hepatitis B vaccine, unspecified formulation retired 58 Hep C hepatitis C vaccine retired 59 Hep E hepatitis E vaccine retired 60 herpes simplex 2 herpes simplex virus, type 2 vaccine retired 46 Hib (PRP-D) Haemophilus influenzae type b vaccine, PRP-D conjugate retired 47 Hib (HbOC) Haemophilus influenzae type b vaccine, HbOC conjugate retired 48 Hib (PRP-T) Haemophilus influenzae type b vaccine, PRP-T conjugate 49 Hib (PRP-OMP) Haemophilus influenzae type b vaccine, PRP-OMP conjugate 17 Hib, unspecified formulation Haemophilus influenzae type b vaccine, conjugate unspecified formulation retired 51 Hib-Hep B Haemophilus influenzae type b conjugate and Hepatitis B vaccine retired 61 HIV human immunodeficiency virus vaccine retired 118 HPV, bivalent human papilloma virus vaccine, bivalent retired 62 HPV, quadrivalent human papilloma virus vaccine, quadrivalent 86 IG immune globulin, intramuscular 87 IGIV immune globulin, intravenous 14 IG, unspecified formulation immune globulin, unspecified formulation retired 111 Influenza, live, trivalent, intranasal, PF Influenza, live, trivalent, intranasal, preservative free 15 influenza, split (incl. purified surface antigen) influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE retired 16 influenza, whole influenza virus vaccine, whole virus retired 88 influenza, unspecified formulation influenza virus vaccine, unspecified formulation retired 123 influenza, H5N1-1203 influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile) retired 10 IPV poliovirus vaccine, inactivated 02 OPV, trivalent trivalent poliovirus vaccine, live, oral retired 89 polio, unspecified formulation poliovirus vaccine, unspecified formulation retired 39 Japanese encephalitis SC Japanese Encephalitis Vaccine SC retired 63 Junin virus Junin virus vaccine retired 64 leishmaniasis leishmaniasis vaccine retired 65 leprosy leprosy vaccine retired 66 Lyme disease Lyme disease vaccine retired 03 MMR measles, mumps and rubella virus vaccine 04 M/R measles and rubella virus vaccine retired 94 MMRV measles, mumps, rubella, and varicella virus vaccine 67 malaria malaria vaccine retired 05 measles measles virus vaccine retired 68 melanoma melanoma vaccine retired 32 meningococcal MPSV4 meningococcal polysaccharide vaccine (MPSV4) retired 103 meningococcal C conjugate meningococcal C conjugate vaccine retired 114 meningococcal MCV4P meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P) 108 meningococcal ACWY, unspecified formulation meningococcal ACWY vaccine, unspecified formulation retired 07 mumps mumps virus vaccine retired 69 parainfluenza-3 parainfluenza-3 virus vaccine retired 11 pertussis pertussis vaccine retired 23 plague plague vaccine retired 33 pneumococcal polysaccharide PPV23 pneumococcal polysaccharide vaccine, 23 valent 100 pneumococcal conjugate PCV 7 pneumococcal conjugate vaccine, 7 valent retired 109 pneumococcal, unspecified formulation pneumococcal vaccine, unspecified formulation retired 70 Q fever Q fever vaccine retired 18 rabies, intramuscular injection rabies vaccine, for intramuscular injection RETIRED CODE retired 40 rabies, intradermal injection rabies vaccine, for intradermal injection retired 90 rabies, unspecified formulation rabies vaccine, unspecified formulation retired 72 rheumatic fever rheumatic fever vaccine retired 73 Rift Valley fever Rift Valley fever vaccine retired 34 RIG rabies immune globulin 119 rotavirus, monovalent rotavirus, live, monovalent vaccine 122 rotavirus, unspecified formulation rotavirus vaccine, unspecified formulation retired 116 rotavirus, pentavalent rotavirus, live, pentavalent vaccine 74 rotavirus, tetravalent rotavirus, live, tetravalent vaccine retired 71 RSV-IGIV respiratory syncytial virus immune globulin, intravenous retired 93 RSV-MAb respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular 06 rubella rubella virus vaccine retired 38 rubella/mumps rubella and mumps virus vaccine retired 76 Staphylococcus bacterio lysate Staphylococcus bacteriophage lysate retired 113 Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) 09 Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) 115 Tdap tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed 35 tetanus toxoid, adsorbed retired 112 tetanus toxoid, unspecified formulation retired 77 Tick-borne encephalitis vaccine (non-US) 13 TIG tetanus immune globulin 95 TST-OT tine test tuberculin skin test; old tuberculin, multipuncture device retired 96 TST-PPD intradermal tuberculin skin test; purified protein derivative solution, intradermal retired 97 TST-PPD tine test tuberculin skin test; purified protein derivative, multipuncture device retired 98 TST, unspecified formulation tuberculin skin test; unspecified formulation retired 78 tularemia vaccine retired 91 typhoid, unspecified formulation typhoid vaccine, unspecified formulation retired 25 typhoid, oral typhoid vaccine, live, oral 41 typhoid, parenteral typhoid vaccine, parenteral, other than acetone-killed, dried retired 53 typhoid, parenteral, AKD (U.S. military) typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) retired 101 typhoid, ViCPs typhoid Vi capsular polysaccharide vaccine 75 Vaccinia (smallpox, monkeypox), live Vaccinia (smallpox, monkeypox) vaccine, live 105 vaccinia (smallpox) diluted vaccinia (smallpox) vaccine, diluted retired 79 vaccinia immune globulin 21 varicella varicella virus vaccine 81 VEE, inactivated Venezuelan equine encephalitis, inactivated retired 80 VEE, live Venezuelan equine encephalitis, live, attenuated retired 92 VEE, unspecified formulation Venezuelan equine encephalitis vaccine, unspecified formulation retired 36 VZIG varicella zoster immune globulin 117 VZIG (IND) varicella zoster immune globulin (Investigational New Drug) retired 37 yellow fever live yellow fever vaccine live 121 zoster live zoster vaccine, live retired 998 no vaccine administered retired 999 unknown unknown vaccine or immune globulin retired 99 RESERVED - do not use retired 133 Pneumococcal conjugate PCV 13 pneumococcal conjugate vaccine, 13 valent 134 Japanese Encephalitis IM Japanese Encephalitis vaccine for intramuscular administration 137 HPV, unspecified formulation retired 136 Meningococcal MCV4O meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O) 135 Influenza, high-dose, trivalent, PF Influenza, high-dose, split virus, trivalent, injectable, preservative free 131 typhus, historical Historical record of a typhus vaccination retired 132 DTaP-IPV-HIB-HEP B, historical Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine. retired 128 Novel Influenza-H1N1-09, all formulations Novel influenza-H1N1-09, all formulations retired 125 Novel Influenza-H1N1-09, nasal Novel Influenza-H1N1-09, live virus for nasal administration retired 126 Novel influenza-H1N1-09, preservative-free Novel influenza-H1N1-09, preservative-free, injectable retired 127 Novel influenza-H1N1-09 Novel influenza-H1N1-09, injectable retired 138 Td (adult) tetanus and diphtheria toxoids, not adsorbed, for adult use retired 139 Td(adult) unspecified formulation retired 140 Influenza, split virus, trivalent, PF Influenza, split virus, trivalent, injectable, preservative free 129 Japanese Encephalitis, unspecified formulation Japanese Encephalitis vaccine, unspecified formulation retired 141 Influenza, split virus, trivalent, preservative Influenza, split virus, trivalent, injectable, contains preservative 142 tetanus toxoid, not adsorbed retired 143 Adenovirus types 4 and 7 Adenovirus, type 4 and type 7, live, oral 144 influenza, seasonal, intradermal, preservative free seasonal influenza, intradermal, preservative free retired 145 RSV-MAb (new) respiratory syncytial virus monoclonal antibody (motavizumab), intramuscular retired 146 DTaP,IPV,Hib,HepB Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine. 147 meningococcal MCV4, unspecified formulation Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135) retired 148 Meningococcal C/Y-HIB PRP Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine retired 149 Influenza, live, quadrivalent, intranasal 150 Influenza, split virus, quadrivalent, PF Influenza, split virus, quadrivalent, injectable, preservative free 151 influenza nasal, unspecified formulation retired 152 Pneumococcal Conjugate, unspecified formulation retired 153 Influenza, MDCK, trivalent, PF Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, preservative free 154 Hep A, IG Hepatitis A immune globulin retired 155 Influenza, recombinant, trivalent, PF Influenza, recombinant, trivalent, injectable, preservative free 156 Rho(D)-IG Rho(D) Immune globulin- IV or IM 157 Rho(D) -IG IM Rho(D) Immune globulin - IM 158 Influenza, split virus, quadrivalent, preservative Influenza, split virus, quadrivalent, injectable, contains preservative 159 Rho(D) - Unspecified formulation Rho(D) Unspecified formulation retired 160 Influenza A monovalent (H5N1), ADJUVANTED-2013 Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013 801 AS03 Adjuvant 161 Influenza, injectable,quadrivalent, preservative free, pediatric 162 meningococcal B, recombinant meningococcal B vaccine, fully recombinant 163 meningococcal B, OMV meningococcal B vaccine, recombinant, OMV, adjuvanted 164 meningococcal B, unspecified meningococcal B, unspecified formulation retired 165 HPV9 Human Papillomavirus 9-valent vaccine 166 influenza, intradermal, quadrivalent, preservative free influenza, intradermal, quadrivalent, preservative free, injectable retired 167 meningococcal, unknown serogroups meningococcal vaccine of unknown formulation and unknown serogroups retired 168 Influenza, adjuvanted, trivalent, PF Influenza, adjuvanted, inactivated, trivalent, injectable, preservative free 169 Hep A, live attenuated Hep A, live attenuated-IM 170 DTAP/IPV/HIB - non-US non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) 171 Influenza, MDCK, quadrivalent, PF Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, preservative free 172 cholera, WC-rBS 173 cholera, BivWC 174 cholera, live attenuated 175 Rabies - IM Diploid cell culture Human Rabies vaccine from human diploid cell culture 176 Rabies - IM fibroblast culture Human rabies vaccine from Chicken fibroblast culture 177 PCV10 pneumococcal conjugate vaccine, 10 valent 178 OPV bivalent Non-US bivalent oral polio vaccine (types 1 and 3) 179 OPV ,monovalent, unspecified Non-US monovalent oral polio vaccine, unspecified formulation 180 tetanus immune globulin retired 181 anthrax immune globulin 182 OPV, Unspecified Oral Polio Vaccine, Unspecified formulation retired 183 Yellow fever vaccine live - alt Yellow fever vaccine live - alternative formulation for vaccine shortage 184 Yellow fever, unspecified Yellow fever vaccine, unspecified formulation retired 185 Influenza, recombinant, quadrivalent, PF Influenza, recombinant, quadrivalent, injectable, preservative free 186 Influenza, MDCK, quadrivalent, preservative Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, contains preservative 187 zoster recombinant zoster vaccine recombinant 188 zoster, unspecified formulation zoster vaccine, unspecified formulation retired 189 HepB-CpG Hepatitis B vaccine (recombinant), CpG adjuvanted 190 Typhoid conjugate vaccine (TCV) Typhoid conjugate vaccine (non-US) 191 meningococcal A polysaccharide (non-US) meningococcal A polysaccharide vaccine (non-US) 192 meningococcal AC polysaccharide (non-US) meningococcal AC polysaccharide vaccine (non-US) 193 Hep A-Hep B, pediatric/adolescent hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US) 194 Influenza, Southern Hemisphere influenza, Southern Hemisphere, unspecified formulation retired 195 DT, IPV adsorbed Diphtheria, Tetanus, Poliomyelitis adsorbed 196 Td, adsorbed, preservative free, adult use, Lf unspecified tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified 197 Influenza, high-dose, quadrivalent, PF Influenza, high-dose, split virus, quadrivalent, injectable, preservative free 200 influenza, Southern Hemisphere, pediatric, preservative free influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free 201 Influenza, Southern Hemisphere, quadrivalent, PF Influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5 mL dose, preservative free 202 influenza, Southern Hemisphere, quadrivalent, with preservative influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative 198 DTP-hepB-Hib Pentavalent Non-US Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent) 203 meningococcal conjugate quadrivalent, MenACWY-TT (MCV4) meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine 0.5mL dose, preservative free 205 Influenza, adjuvanted, quadrivalent, PF Influenza, adjuvanted, inactivated, quadrivalent, injectable, preservative free 206 Vaccinia, smallpox monkeypox vaccine live, PF, SQ or ID injection Vaccinia, smallpox monkeypox vaccine, live attenuated, preservative free, subcutaneous or intradermal injection 207 COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose retired 208 COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose retired 213 SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED retired 210 COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL 212 COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL retired 204 Ebola Zaire vaccine, live, recombinant, 1mL dose 214 Ebola, unspecified retired 211 COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose retired 500 COVID-19 Non-US Vaccine, UNSPECIFIED SARS-COV-2 (COVID-19) Non-US Vaccine, UNSPECIFIED 501 COVID-19 IV Non-US Vaccine (QAZCOVID-IN) SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN) 502 COVID-19 IV Non-US Vaccine (COVAXIN) SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN) 503 COVID-19 LAV Non-US Vaccine (COVIVAC) SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC) 504 COVID-19 VVnr Non-US Vaccine (Sputnik Light) SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light) 505 COVID-19 VVnr Non-US Vaccine (Sputnik V) SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V) 506 COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology 507 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences) SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences) 508 COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention) SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention) 509 COVID-19 PS Non-US Vaccine (EpiVacCorona) SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona) 510 COVID-19 IV Non-US Vaccine (BIBP, Sinopharm) SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm) 511 COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac) 215 Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF Pneumococcal conjugate vaccine 15-valent (PCV15), polysaccharide CRM197 conjugate, adjuvant, preservative free 216 Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF Pneumococcal conjugate vaccine 20-valent (PCV20), polysaccharide CRM197 conjugate, adjuvant, preservative free 219 COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation retired 217 COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation retired 218 COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation retired 220 HepB recombinant, 3-antigen, Al(OH)3 Hepatitis B vaccine (recombinant), 3-antigen, Al(OH)3 adjuvanted retired 221 COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose retired 222 Tick-borne encephalitis, unspecified Tick-borne encephalitis vaccine, unspecified retired 223 Tick-borne encephalitis, inactivated, PF, 0.25mL Tick-borne encephalitis vaccine, inactivated, preservative free, 0.25mL dose 224 Tick-borne encephalitis, inactivated, PF, 0.5mL Tick-borne encephalitis vaccine, inactivated, preservative free, 0.5mL dose 225 COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 5mcg/0.5mL dose retired 226 COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 10mcg/0.5mL dose retired 512 SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz) SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz) 513 SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax) SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax) 514 SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D) SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D) 515 SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901) SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901) 516 COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) 517 SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax) SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax) 227 COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL dose retired 228 COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose retired 229 COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose retired 301 COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation retired 300 COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation retired 230 COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose retired 518 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) 519 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna 520 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech 521 COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK SARS-COV-2 (COVID-19) vaccine SP, protein-based, adjuvanted, B.1.351 strain (VidPrevtyn Beta), Sanofi-GSK 231 influenza, Southern Hemisphere, high-dose, quadrivalent influenza, seasonal, Southern Hemisphere, high-dose, quadrivalent, 0.7mL dose, preservative free 303 RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF Respiratory syncytial virus (RSV), vaccine, recombinant, protein subunit RSV prefusion F, adjuvant reconstituted, 0.5 mL, preservative free 304 Respiratory syncytial virus (RSV), unspecified retired 305 RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF Respiratory syncytial virus (RSV), vaccine, bivalent, protein subunit RSV prefusion F, diluent reconstituted, 0.5 mL, preservative free 306 RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 0.5 mL, neonates and children to 24 months 307 RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 1 mL, neonates and children to 24 months 313 COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 5 mcg/0.5 mL dose 308 COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 3 mcg/0.3 mL dose retired 309 COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 30 mcg/0.3 mL dose 310 COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 10 mcg/0.3 mL dose 312 COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose 311 COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 25 mcg/0.25 mL dose 315 Respiratory syncytial virus (RSV) MAB, unspecified Respiratory syncytial virus (RSV) monoclonal antibody (MAB), unspecified retired 314 Respiratory syncytial virus (RSV) vaccine, unspecified retired 316 Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF Meningococcal polysaccharide (groups A, C, Y, W) tetanus toxoid conjugate, meningococcal B recombinant vaccine, 0.5mL, preservative free 317 Chikungunya live attenuated vaccine, 0.5 mL, PF Chikungunya, live attenuated vaccine, 0.5 mL, preservative free 318 Anthrax, post-exposure prophylaxis Anthrax vaccine, adsorbed, adjuvanted, post-exposure prophylaxis 319 Anthrax vaccine, unspecified retired 320 Influenza, MDCK, trivalent, preservative Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, contains preservative 321 Influenza-avian, H5N8, monovalent, PF Influenza-avian, H5N8, viral-vector, monovalent, injectable, preservative free 322 Influenza-avian, H5N8, monovalent, preservative Influenza-avian, H5N8, viral-vector, monovalent, injectable, contains preservative 324 Poliovirus, inactivated, fractional-dose (fIPV) 323 Influenza-avian, H5, unspecified formulation retired 326 RSV, mRNA, injectable, PF Respiratory syncytial virus (RSV), mRNA, injectable, preservative free 327 Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PF Pneumococcal conjugate vaccine, 21 valent (PCV21), polysaccharide CRM197 conjugate, preservative free 328 Meningococcal oligosaccharide (MenACWY), (MenB), PF Meningococcal oligosaccharide conjugated (groups A, C, W, Y) and group B, 0.5 mL, preservative free 329 Chikungunya, VLP, recombinant, 0.8 mL, PF Chikungunya, virus-like particle (VLP), recombinant vaccine, 0.8 mL, preservative free 330 Dengue fever, unspecified Dengue fever, unspecified formulation retired 331 Influenza, Southern Hemisphere, trivalent, PF Influenza, seasonal, Southern Hemisphere, trivalent, 0.5 mL dose, preservative free 325 Vaccinia (smallpox, monkeypox), unspecified retired 332 RSV, mAb, clesrovimab-cfor, 0.7 mL, neonate and infant, PF Respiratory syncytial virus (RSV), monoclonal antibody, IgG1κ, (clesrovimab-cfor), 0.7 mL, neonate and infant, preservative free 333 Influenza, live, trivalent, intranasal, self/caregiver admin, PF Influenza, live, trivalent, intranasal, self or caregiver administered, preservative free 334 COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2 mL dose 337 Influenza, Southern Hemisphere, high-dose, trivalent, PF Influenza, Southern Hemisphere, high-dose, split virus, trivalent, 0.5 mL, injectable, preservative free 302 COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation retired
Эрүүл мэндийн хөгжлийн төв (Health Development Center, Mongolia)
Эрүүл мэндийн хөгжлийн төв (Health Development Center)
CDC CVX кодын жагсаалт. Дархлаажуулалтын вакциныг кодлоход ашиглана. Эх сурвалж: CDC (https://www2a.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx)
adenovirus vaccine, unspecified formulation
Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis
Anthrax vaccine, adsorbed, pre-exposure and post-exposure prophylaxis
cholera vaccine, unspecified formulation
cytomegalovirus immune globulin, intravenous
diphtheria and tetanus toxoids, adsorbed for pediatric use
diphtheria, tetanus toxoids and acellular pertussis vaccine
diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens
diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation
DTaP-Haemophilus influenzae type b conjugate vaccine
diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)
Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated
diphtheria, tetanus toxoids and pertussis vaccine
DTP-Haemophilus influenzae type b conjugate vaccine
DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine
hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule
hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule
Hep A, pediatric, unspecified formulation
hepatitis A vaccine, pediatric dosage, unspecified formulation
hepatitis A vaccine, unspecified formulation
hepatitis B vaccine, pediatric or pediatric/adolescent dosage
hepatitis B vaccine, adolescent/high risk infant dosage
Hepatitis B vaccine (Hep B), high-dosage, dialysis or immunocompromised patient
hepatitis B vaccine, unspecified formulation
Haemophilus influenzae type b vaccine, PRP-D conjugate
Haemophilus influenzae type b vaccine, HbOC conjugate
Haemophilus influenzae type b vaccine, PRP-T conjugate
Haemophilus influenzae type b vaccine, PRP-OMP conjugate
Haemophilus influenzae type b vaccine, conjugate unspecified formulation
Haemophilus influenzae type b conjugate and Hepatitis B vaccine
human papilloma virus vaccine, quadrivalent
immune globulin, unspecified formulation
Influenza, live, trivalent, intranasal, PF
Influenza, live, trivalent, intranasal, preservative free
influenza, split (incl. purified surface antigen)
influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE
influenza virus vaccine, unspecified formulation
influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile)
trivalent poliovirus vaccine, live, oral
poliovirus vaccine, unspecified formulation
measles, mumps and rubella virus vaccine
measles, mumps, rubella, and varicella virus vaccine
meningococcal polysaccharide vaccine (MPSV4)
meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P)
meningococcal ACWY, unspecified formulation
meningococcal ACWY vaccine, unspecified formulation
pneumococcal polysaccharide vaccine, 23 valent
pneumococcal conjugate vaccine, 7 valent
pneumococcal vaccine, unspecified formulation
rabies vaccine, for intramuscular injection RETIRED CODE
rabies vaccine, for intradermal injection
rotavirus vaccine, unspecified formulation
respiratory syncytial virus immune globulin, intravenous
respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular
Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed
tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)
Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed
tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)
tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed
Tick-borne encephalitis vaccine (non-US)
tuberculin skin test; old tuberculin, multipuncture device
tuberculin skin test; purified protein derivative solution, intradermal
tuberculin skin test; purified protein derivative, multipuncture device
tuberculin skin test; unspecified formulation
typhoid vaccine, unspecified formulation
typhoid vaccine, parenteral, other than acetone-killed, dried
typhoid, parenteral, AKD (U.S. military)
typhoid vaccine, parenteral, acetone-killed, dried (U.S. military)
typhoid Vi capsular polysaccharide vaccine
Vaccinia (smallpox, monkeypox) vaccine, live
Venezuelan equine encephalitis, inactivated
Venezuelan equine encephalitis, live, attenuated
Venezuelan equine encephalitis vaccine, unspecified formulation
varicella zoster immune globulin (Investigational New Drug)
pneumococcal conjugate vaccine, 13 valent
Japanese Encephalitis vaccine for intramuscular administration
meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O)
Influenza, high-dose, split virus, trivalent, injectable, preservative free
Historical record of a typhus vaccination
Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine.
Novel Influenza-H1N1-09, all formulations
Novel influenza-H1N1-09, all formulations
Novel Influenza-H1N1-09, live virus for nasal administration
Novel influenza-H1N1-09, preservative-free
Novel influenza-H1N1-09, preservative-free, injectable
tetanus and diphtheria toxoids, not adsorbed, for adult use
Influenza, split virus, trivalent, injectable, preservative free
Japanese Encephalitis, unspecified formulation
Japanese Encephalitis vaccine, unspecified formulation
Influenza, split virus, trivalent, preservative
Influenza, split virus, trivalent, injectable, contains preservative
Adenovirus, type 4 and type 7, live, oral
influenza, seasonal, intradermal, preservative free
seasonal influenza, intradermal, preservative free
respiratory syncytial virus monoclonal antibody (motavizumab), intramuscular
Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine.
meningococcal MCV4, unspecified formulation
Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135)
Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine
Influenza, live, quadrivalent, intranasal
Influenza, split virus, quadrivalent, PF
Influenza, split virus, quadrivalent, injectable, preservative free
influenza nasal, unspecified formulation
Pneumococcal Conjugate, unspecified formulation
Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, preservative free
Influenza, recombinant, trivalent, injectable, preservative free
Influenza, split virus, quadrivalent, preservative
Influenza, split virus, quadrivalent, injectable, contains preservative
Influenza A monovalent (H5N1), ADJUVANTED-2013
Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013
Influenza, injectable,quadrivalent, preservative free, pediatric
meningococcal B vaccine, fully recombinant
meningococcal B vaccine, recombinant, OMV, adjuvanted
meningococcal B, unspecified formulation
influenza, intradermal, quadrivalent, preservative free
influenza, intradermal, quadrivalent, preservative free, injectable
meningococcal vaccine of unknown formulation and unknown serogroups
Influenza, adjuvanted, inactivated, trivalent, injectable, preservative free
non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)
Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, preservative free
Human Rabies vaccine from human diploid cell culture
Human rabies vaccine from Chicken fibroblast culture
pneumococcal conjugate vaccine, 10 valent
Non-US bivalent oral polio vaccine (types 1 and 3)
Non-US monovalent oral polio vaccine, unspecified formulation
Oral Polio Vaccine, Unspecified formulation
Yellow fever vaccine live - alternative formulation for vaccine shortage
Yellow fever vaccine, unspecified formulation
Influenza, recombinant, quadrivalent, PF
Influenza, recombinant, quadrivalent, injectable, preservative free
Influenza, MDCK, quadrivalent, preservative
Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, contains preservative
Hepatitis B vaccine (recombinant), CpG adjuvanted
meningococcal A polysaccharide vaccine (non-US)
meningococcal AC polysaccharide (non-US)
meningococcal AC polysaccharide vaccine (non-US)
hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US)
influenza, Southern Hemisphere, unspecified formulation
Diphtheria, Tetanus, Poliomyelitis adsorbed
Td, adsorbed, preservative free, adult use, Lf unspecified
tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified
Influenza, high-dose, split virus, quadrivalent, injectable, preservative free
influenza, Southern Hemisphere, pediatric, preservative free
influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free
Influenza, Southern Hemisphere, quadrivalent, PF
Influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5 mL dose, preservative free
influenza, Southern Hemisphere, quadrivalent, with preservative
influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative
Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent)
meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)
meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine 0.5mL dose, preservative free
Influenza, adjuvanted, inactivated, quadrivalent, injectable, preservative free
Vaccinia, smallpox monkeypox vaccine live, PF, SQ or ID injection
Vaccinia, smallpox monkeypox vaccine, live attenuated, preservative free, subcutaneous or intradermal injection
COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose
COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose
SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED
COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL
SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL
COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL
SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL
Ebola Zaire vaccine, live, recombinant, 1mL dose
COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL
SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose
SARS-COV-2 (COVID-19) Non-US Vaccine, UNSPECIFIED
COVID-19 IV Non-US Vaccine (QAZCOVID-IN)
SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN)
SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN)
SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC)
COVID-19 VVnr Non-US Vaccine (Sputnik Light)
SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light)
COVID-19 VVnr Non-US Vaccine (Sputnik V)
SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V)
COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology
SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology
COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences)
COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention)
COVID-19 PS Non-US Vaccine (EpiVacCorona)
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona)
COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)
SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm)
COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)
SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac)
Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF
Pneumococcal conjugate vaccine 15-valent (PCV15), polysaccharide CRM197 conjugate, adjuvant, preservative free
Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF
Pneumococcal conjugate vaccine 20-valent (PCV20), polysaccharide CRM197 conjugate, adjuvant, preservative free
COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation
COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation
COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation
Hepatitis B vaccine (recombinant), 3-antigen, Al(OH)3 adjuvanted
COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose
Tick-borne encephalitis vaccine, unspecified
Tick-borne encephalitis, inactivated, PF, 0.25mL
Tick-borne encephalitis vaccine, inactivated, preservative free, 0.25mL dose
Tick-borne encephalitis, inactivated, PF, 0.5mL
Tick-borne encephalitis vaccine, inactivated, preservative free, 0.5mL dose
COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL
SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 5mcg/0.5mL dose
COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL
SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 10mcg/0.5mL dose
SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)
SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz)
SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax)
SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)
SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D)
SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901)
COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)
SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)
SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax)
COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL dose
COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose
COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose
COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation
COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation
COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose
COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)
SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)
COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna
SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna
COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech
SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech
COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK
SARS-COV-2 (COVID-19) vaccine SP, protein-based, adjuvanted, B.1.351 strain (VidPrevtyn Beta), Sanofi-GSK
influenza, Southern Hemisphere, high-dose, quadrivalent
influenza, seasonal, Southern Hemisphere, high-dose, quadrivalent, 0.7mL dose, preservative free
RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF
Respiratory syncytial virus (RSV), vaccine, recombinant, protein subunit RSV prefusion F, adjuvant reconstituted, 0.5 mL, preservative free
Respiratory syncytial virus (RSV), unspecified
RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF
Respiratory syncytial virus (RSV), vaccine, bivalent, protein subunit RSV prefusion F, diluent reconstituted, 0.5 mL, preservative free
RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months
Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 0.5 mL, neonates and children to 24 months
RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months
Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 1 mL, neonates and children to 24 months
COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL
SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 5 mcg/0.5 mL dose
COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 3 mcg/0.3 mL dose
COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 30 mcg/0.3 mL dose
COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 10 mcg/0.3 mL dose
COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL
COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 25 mcg/0.25 mL dose
Respiratory syncytial virus (RSV) MAB, unspecified
Respiratory syncytial virus (RSV) monoclonal antibody (MAB), unspecified
Respiratory syncytial virus (RSV) vaccine, unspecified
Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF
Meningococcal polysaccharide (groups A, C, Y, W) tetanus toxoid conjugate, meningococcal B recombinant vaccine, 0.5mL, preservative free
Chikungunya live attenuated vaccine, 0.5 mL, PF
Chikungunya, live attenuated vaccine, 0.5 mL, preservative free
Anthrax vaccine, adsorbed, adjuvanted, post-exposure prophylaxis
Influenza, MDCK, trivalent, preservative
Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, contains preservative
Influenza-avian, H5N8, viral-vector, monovalent, injectable, preservative free
Influenza-avian, H5N8, monovalent, preservative
Influenza-avian, H5N8, viral-vector, monovalent, injectable, contains preservative
Poliovirus, inactivated, fractional-dose (fIPV)
Influenza-avian, H5, unspecified formulation
Respiratory syncytial virus (RSV), mRNA, injectable, preservative free
Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PF
Pneumococcal conjugate vaccine, 21 valent (PCV21), polysaccharide CRM197 conjugate, preservative free
Meningococcal oligosaccharide (MenACWY), (MenB), PF
Meningococcal oligosaccharide conjugated (groups A, C, W, Y) and group B, 0.5 mL, preservative free
Chikungunya, VLP, recombinant, 0.8 mL, PF
Chikungunya, virus-like particle (VLP), recombinant vaccine, 0.8 mL, preservative free
Influenza, Southern Hemisphere, trivalent, PF
Influenza, seasonal, Southern Hemisphere, trivalent, 0.5 mL dose, preservative free
Vaccinia (smallpox, monkeypox), unspecified
RSV, mAb, clesrovimab-cfor, 0.7 mL, neonate and infant, PF
Respiratory syncytial virus (RSV), monoclonal antibody, IgG1κ, (clesrovimab-cfor), 0.7 mL, neonate and infant, preservative free
Influenza, live, trivalent, intranasal, self/caregiver admin, PF
Influenza, live, trivalent, intranasal, self or caregiver administered, preservative free
COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2 mL dose
Influenza, Southern Hemisphere, high-dose, trivalent, PF
Influenza, Southern Hemisphere, high-dose, split virus, trivalent, 0.5 mL, injectable, preservative free
COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation